Dr. Thomas Colletti
Purpose: The purpose of this article is to review the treatment of bruxism with botulinum toxin and examine the level of myofascial pain reduction.
Method: A PubMed literature search was conducted focusing on randomized clinical trials with publishing dates from May 2016 through the present, with search terms of bruxism, botulinum toxin, and myofascial pain reduction. Three articles matched the search terms.
Results: Botulinum toxin has been found to reduce myofascial pain caused by bruxism. Further studies need to be conducted to determine the lowest, most effective dosing.
Conclusion: Multiple modalities can be used to treat bruxism. While there is no cure to permanently stop bruxism, botulinum toxin has been found to reduce myofascial pain by lessening overactive masseter muscles. Further research is needed to establish lowest effective dosing guidelines.
Aman PM. Efficacy of Botulinum Toxin in Treatment of Bruxism. Lynchburg Journal of Medical Science. 2022; 4(2).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.